image_300x180_fit_478b24840a

Fidelis signs distribution agreement with KAC Co., Ltd., Japan

Fidelis Research to start offering biospecimen procurement services on the Japanese market through distribution agreement with KAC Co., Ltd.

SOFIA, BULGARIA, 21 Oct 2020

The company now offers its bespoke sample collection solutions to customers in Japan through a non-exclusive distribution agreement with Japanese partner KAC Co., Ltd. The collaboration will see Fidelis expand its customer base and help customers in Japan access high quality tissue and biofluid samples for their research.

Fidelis supports researchers in complex projects tailored specifically to their needs for high quality samples annotated with rich clinical, pathology and genomic data to help accelerate their translational work. By working closely with sites to access patient samples and laboratories in each country to run custom processing protocols, Fidelis can quickly scale projects to achieve optimal results with efficient timelines for projects across therapeutic areas and diseases.

Fidelis Research (https://fidelis-research.com/) is a privately-owned contract research company focused on the custom procurement and processing of human biological samples from disease state patients. Headquartered in Sofia, Bulgaria, Fidelis also has own operations in Croatia, Moldova, Romania, Serbia and Turkey, thus covering a large network of over 60 collection sites in Europe with the capability to ship samples rapidly to clients around the world.  

KAC Co., (https://www.kacnet.co.jp/en/) established in 1978, have been offering variety of services to help the pharmaceutical research and development. Having three divisions the Animal Care Division, the Bioscience Division, and the Reagent Business Division, focusing on the Reagent since it started operations in 1994, has provided high quality products - human tissue derived products such as blood, hepatic cells and others.

contact-popup
Contact us